QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
1-Year Return
19.13%
This Quarter Return
-13.89%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$744M
AUM Growth
-$81.5M
(-9.9%)
Cap. Flow
+$41.6M
Cap. Flow
% of AUM
5.59%
Top 10 Holdings %
Top 10 Hldgs %
31.55%
Holding
2,874
New
241
Increased
1,415
Reduced
721
Closed
183
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.79M |
| 2 |
FIGS
FIGS
|
+$5.02M |
| 3 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$3.58M |
| 4 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$3.4M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$2.19M |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$4M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$3.23M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.1M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$1.06M |
| 5 |
RMI
RiverNorth Opportunistic Municipal Income Fund
RMI
|
+$900K |
Sector Composition
| 1 | Technology | 12.36% |
| 2 | Healthcare | 7.65% |
| 3 | Financials | 6.69% |
| 4 | Consumer Staples | 6.68% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Eletrobras Common Shares
EBR
$19.1B
| $3K | ﹤0.01% |
+330
| New | +$3K |
|
2102
Emergent Biosolutions
EBS
$425M
| $3K | ﹤0.01% |
105
-26
| -20% | -$743 |
|
2103
First American
FAF
$6.74B
| $3K | ﹤0.01% |
65
| – | – |
|
2104
National Beverage
FIZZ
$3.68B
| $3K | ﹤0.01% |
60
| – | – |
|
2105
Graham Holdings Company
GHC
$4.97B
| $3K | ﹤0.01% |
6
+1
| +20% | +$500 |
|
2106
Golar LNG
GLNG
$4.27B
| $3K | ﹤0.01% |
126
| – | – |
|
2107
Green Brick Partners
GRBK
$3.17B
| $3K | ﹤0.01% |
132
| – | – |
|
2108
Gorman-Rupp
GRC
$1.12B
| $3K | ﹤0.01% |
97
-54
| -36% | -$1.67K |
|
2109
HealthStream
HSTM
$839M
| $3K | ﹤0.01% |
117
+100
| +588% | +$2.56K |
|
2110
Hilltop Holdings
HTH
$2.19B
| $3K | ﹤0.01% |
+99
| New | +$3K |
|
2111
MarineMax
HZO
$545M
| $3K | ﹤0.01% |
75
| – | – |
|
2112
IDEAYA Biosciences
IDYA
$2.17B
| $3K | ﹤0.01% |
+186
| New | +$3K |
|
2113
Iovance Biotherapeutics
IOVA
$861M
| $3K | ﹤0.01% |
259
-22
| -8% | -$255 |
|
2114
JELD-WEN Holding
JELD
$537M
| $3K | ﹤0.01% |
181
+51
| +39% | +$845 |
|
2115
Jackson Financial
JXN
$6.75B
| $3K | ﹤0.01% |
106
-16
| -13% | -$453 |
|
2116
Kyndryl
KD
$7.49B
| $3K | ﹤0.01% |
338
-29
| -8% | -$257 |
|
2117
Leggett & Platt
LEG
$1.35B
| $3K | ﹤0.01% |
93
+44
| +90% | +$1.42K |
|
2118
Lennar Class B
LEN.B
$33.8B
| $3K | ﹤0.01% |
49
+21
| +75% | +$1.29K |
|
2119
LeMaitre Vascular
LMAT
$2.1B
| $3K | ﹤0.01% |
71
+46
| +184% | +$1.94K |
|
2120
Light & Wonder
LNW
$7.43B
| $3K | ﹤0.01% |
55
+33
| +150% | +$1.8K |
|
2121
Lyft
LYFT
$7.87B
| $3K | ﹤0.01% |
199
-328
| -62% | -$4.95K |
|
2122
Medifast
MED
$152M
| $3K | ﹤0.01% |
19
+10
| +111% | +$1.58K |
|
2123
Monro
MNRO
$507M
| $3K | ﹤0.01% |
75
+41
| +121% | +$1.64K |
|
2124
Myriad Genetics
MYGN
$642M
| $3K | ﹤0.01% |
187
+94
| +101% | +$1.51K |
|
2125
National Bank Holdings
NBHC
$1.47B
| $3K | ﹤0.01% |
+77
| New | +$3K |
|